345 related articles for article (PubMed ID: 15965673)
1. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.
Brignole F; Pisella PJ; Dupas B; Baeyens V; Baudouin C
Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):531-8. PubMed ID: 15965673
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease.
Lee JH; Ahn HS; Kim EK; Kim TI
Cornea; 2011 Feb; 30(2):175-9. PubMed ID: 21045674
[TBL] [Abstract][Full Text] [Related]
3. Comparison of in vivo efficacy of different ocular lubricants in dry eye animal models.
Zheng X; Goto T; Ohashi Y
Invest Ophthalmol Vis Sci; 2014 Apr; 55(6):3454-60. PubMed ID: 24781937
[TBL] [Abstract][Full Text] [Related]
4. Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye.
Labetoulle M; Chiambaretta F; Shirlaw A; Leaback R; Baudouin C
Eye (Lond); 2017 Oct; 31(10):1409-1416. PubMed ID: 28452989
[TBL] [Abstract][Full Text] [Related]
5. Randomized, phase III study comparing osmoprotective carboxymethylcellulose with sodium hyaluronate in dry eye disease.
Baudouin C; Cochener B; Pisella PJ; Girard B; Pouliquen P; Cooper H; Creuzot-Garcher C
Eur J Ophthalmol; 2012; 22(5):751-61. PubMed ID: 22287172
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study.
Sanchez MA; Torralbo-Jimenez P; Giron N; de la Heras B; Herrero Vanrell R; Arriola-Villalobos P; Diaz-Valle D; Alvarez-Barrientos A; Benitez-Del-Castillo JM
Cornea; 2010 Feb; 29(2):167-71. PubMed ID: 20023577
[TBL] [Abstract][Full Text] [Related]
7. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery.
Mencucci R; Boccalini C; Caputo R; Favuzza E
J Cataract Refract Surg; 2015 Aug; 41(8):1699-704. PubMed ID: 26432128
[TBL] [Abstract][Full Text] [Related]
8. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
[TBL] [Abstract][Full Text] [Related]
9. A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients.
Takamura E; Tsubota K; Watanabe H; Ohashi Y;
Br J Ophthalmol; 2012 Oct; 96(10):1310-5. PubMed ID: 22914501
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
11. Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.
Johnson ME; Murphy PJ; Boulton M
Optom Vis Sci; 2008 Aug; 85(8):750-7. PubMed ID: 18677239
[TBL] [Abstract][Full Text] [Related]
12. Effect of hypotonic 0.18% sodium hyaluronate eyedrops on inflammation of the ocular surface in experimental dry eye.
Oh HJ; Li Z; Park SH; Yoon KC
J Ocul Pharmacol Ther; 2014 Sep; 30(7):533-42. PubMed ID: 24766323
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
14. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
Hwang HS; Sung YM; Lee WS; Kim EC
Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
[TBL] [Abstract][Full Text] [Related]
15. Effects of sodium hyaluronate on wavefront aberrations in dry eye patients.
Lekhanont K; Chuckpaiwong V; Vongthongsri A; Sangiampornpanit T
Optom Vis Sci; 2014 Jan; 91(1):39-46. PubMed ID: 24366433
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.
Park Y; Song JS; Choi CY; Yoon KC; Lee HK; Kim HS
J Ocul Pharmacol Ther; 2017 Mar; 33(2):66-72. PubMed ID: 27929721
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 0.3% Hypotonic and Isotonic Sodium Hyaluronate Eye Drops in the Treatment of Experimental Dry Eye.
Li Y; Cui L; Lee HS; Kang YS; Choi W; Yoon KC
Curr Eye Res; 2017 Aug; 42(8):1108-1114. PubMed ID: 28441078
[TBL] [Abstract][Full Text] [Related]
18. Comparing the efficacy of sodium hyaluronate eye drops and carboxymethylcellulose eye drops in treating mild to moderate dry eye disease.
Salim S; Kamath SJ; Jeganathan S; Pai SG; Mendonca TM; Kamath AR
Indian J Ophthalmol; 2023 Apr; 71(4):1593-1597. PubMed ID: 37026307
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease.
Baeyens V; Bron A; Baudouin C;
J Fr Ophtalmol; 2012 Jun; 35(6):412-9. PubMed ID: 22483761
[TBL] [Abstract][Full Text] [Related]
20. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye.
Aragona P; Papa V; Micali A; Santocono M; Milazzo G
Br J Ophthalmol; 2002 Feb; 86(2):181-4. PubMed ID: 11815344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
